Moderna reinstated with an Underperform at BofA - Yahoo Finance
| M1RN34 Stock | BRL 12.10 0.05 0.41% |
About 61% of Moderna's investor base is looking to short. The analysis of current outlook of investing in Moderna suggests that many traders are alarmed regarding Moderna's prospects. The current market sentiment, together with Moderna's historical and current headlines, can help investors time the market. In addition, many technical investors use Moderna stock news signals to limit their universe of possible portfolio assets.
Moderna |
Moderna reinstated with an Underperform at BofA Yahoo Finance
Read at news.google.com
 |
Moderna Fundamental Analysis
We analyze Moderna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Moderna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Moderna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Moderna is regarded third in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Moderna Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Moderna stock to make a market-neutral strategy. Peer analysis of Moderna could also be used in its relative valuation, which is a method of valuing Moderna by comparing valuation metrics with similar companies.
Peers
Moderna Related Equities
| BIOM3 | Biomm SA | 6.74 | ||||
| N1VO34 | Novo Nordisk | 6.39 | ||||
| VRTX34 | Vertex Pharmaceuticals | 2.42 | ||||
| T1CH34 | Bio Techne | 1.31 | ||||
| B1NT34 | BIONTECH | 0.87 | ||||
| M1RN34 | Moderna | 0.41 | ||||
| A1SN34 | Ascendis Pharma | 0.00 | ||||
| B1GN34 | BeiGene | 3.34 |
Complementary Tools for Moderna Stock analysis
When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |